• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 04/27/15

    • 30-Day SEC Yield1

      1.72%
    • Total Net Assets

      $381.7M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.42%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      06/30/2015
  • Portfolio Composition (%)
    as of 04/27/15

    • % of Net Assets
    • Stocks

      100.08
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.08
  • Download All HoldingsAll Holdings (%) as of 04/27/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    353,086
    36,689,1669.61
    Johnson & Johnson
    JNJ US
    316,962
    31,880,0388.35
    Pfizer Inc
    PFE US
    740,742
    25,622,2666.71
    Novo Nordisk A/S
    NVO US
    391,411
    22,224,3175.82
    Sanofi
    SNY US
    383,734
    20,061,6145.26
    Abbvie Inc
    ABBV US
    286,253
    18,612,1704.88
    Glaxosmithkline Plc
    GSK US
    394,661
    18,489,8684.84
    Merck & Co Inc
    MRK US
    321,233
    18,342,4044.81
    Astrazeneca Plc
    AZN US
    251,513
    17,797,0604.66
    Actavis Plc
    ACT US
    61,488
    17,535,7634.59
    Valeant Pharmaceuticals International I
    VRX US
    83,671
    16,903,2154.43
    Eli Lilly & Co
    LLY US
    236,751
    16,783,2784.40
    Abbott Laboratories
    ABT US
    350,061
    16,624,3974.36
    Bristol-Myers Squibb Co
    BMY US
    247,062
    16,098,5604.22
    Teva Pharmaceutical Industries Ltd
    TEVA US
    253,539
    15,625,6094.09
    Shire Plc
    SHPG US
    61,366
    15,277,0664.00
    Mckesson Corp
    MCK US
    60,938
    13,843,2853.63
    Mylan Inc/Pa
    MYL US
    127,830
    9,167,9682.40
    Perrigo Co
    PRGO US
    43,921
    8,269,4462.17
    Amerisourcebergen Corp
    ABC US
    63,782
    7,278,1641.91
    Zoetis Inc
    ZTS US
    131,067
    6,137,8681.61
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    42,007
    3,807,5141.00
    Mallinckrodt Plc
    MNK US
    30,064
    3,467,8820.91
    Hospira Inc
    HSP US
    34,964
    3,050,2590.80
    Jazz Pharmaceuticals Plc
    JAZZ US
    13,138
    2,404,1230.63
    Other/Cash
    -317,079-0.08
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.